Stability of nifedipine in two oral suspensions stored at two temperatures
Related Experiment Video
Updated: Sep 28, 2026

A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients
Published on: August 9, 2022
Milap C Nahata1, Richard S Morosco, Elizabeth A Willhite
1Division of Pharmacy Practice and Administration, College of Pharmacy, Ohio State University and Children's Hospital, Columbus 43210, USA. nahata1@osu.edu
Objective:
To determine the stability of nifedipine in two oral suspensions stored at 4 degrees C and 25 degrees C in plastic prescription bottles over a 3-month period.
Design:
Two suspensions were prepared: 1% methylcellulose:simple syrup NF (1:13) stored in ten 2 oz bottles; and Ora Plus:Ora Sweet (1:1) at a nifedipine concentration of 4 mg/mL also stored in ten 2 oz bottles. Five bottles of each formulation were stored at 4 degrees C, and the rest of the bottles were stored at 25 degrees C. Three samples were collected from each bottle at 0, 7, 14, 28, 42, 56, 70, and 91 days and analyzed by a stability-indicating high-performance liquid chromatography analytic method (n = 15).
Setting:
Laboratory.
Results:
At 4 degrees C, the mean concentration of nifedipine was nearly 100% that of the original concentration in both the Ora Plus-Ora Sweet and the 1% methylcellulose-syrup formulations during the 3-month study period. At 25 degrees C, the mean +/- standard deviation concentration of nifedipine was 98.9% +/- 2.36% of the initial concentration in the Ora Plus-Ora Sweet and 97.4% +/- 2.48% in the 1% methylcellulose-syrup formulation over the 3-month period. No changes in pH or physical appearance were observed.
Conclusion:
Nifedipine can be prepared in two liquid dosage forms and stored for up to 3 months under refrigeration or at room temperature.
Related Concept Videos
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Drug Product Stability
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
IV Infusion to Oral Dosing: Conversion Methods

